Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers.
Cancer Discov
; 8(6): 686-695, 2018 06.
Article
in En
| MEDLINE
| ID: mdl-29610121
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oncogene Proteins, Fusion
/
Neuregulin-1
/
Antibodies, Monoclonal, Humanized
/
Afatinib
/
Neoplasms
Type of study:
Prognostic_studies
Limits:
Aged80
/
Animals
/
Female
/
Humans
/
Male
Language:
En
Journal:
Cancer Discov
Year:
2018
Document type:
Article